Thursday, June 24, 2021
Home National DCGI approves DRDO's 2-DG drug for emergency use in COVID-19 treatment

DCGI approves DRDO’s 2-DG drug for emergency use in COVID-19 treatment

Oral drug 2-deoxy-D-glucose (2-DG), created by DRDO‘s lab Institute of Nuclear Medicine and Allied Sciences in association with Dr. Reddy’s lab, has been approved for emergency use in India by DCGI. As India is witnessing the havoc of the second wave of COVID-19 pandemic, this drug can prove to be very beneficial for the early recovery of patients. In April 2020, during the first wave of the pandemic in the country, the INMAS-DRDO scientists conducted experiments with the help of Hyderabad’s Center for Cellular and Molecular Biology (CCMB) and found that this molecule works effectively against SARS-CoV-2 virus. 2-DG will come in powder form and will be consumed by dissolving in water.

Read more: India Today | Business Standard | News 18

50% LikesVS
50% Dislikes

News Verification For Headline Auditors

If this seems like a news that is relevant to your industry. Would you like to verify the authenticity of the news?
Please Enter your Secret Key

We are building a board of industry expert to help us verify important news stories. If you would like to empanel yourself, please click here.

Report Post

Avantika Yadav
23, Content Editor @HeadlineEnglish @HeadlineHindi